Impara, E.
Bakolis, I.
Bécares, L.
Dasch, H.
Dregan, A.
Dyer, J.
Hotopf, M.
Stewart, R. J.
Stuart, R.
Ocloo, J.
Das-Munshi, J. http://orcid.org/0000-0002-3913-6859
Funding for this research was provided by:
The Health Foundation (2238180)
National Institute for Health Research
Economic and Social Research Council
Nuffield Foundation
Article History
Received: 11 November 2021
Accepted: 5 May 2022
First Online: 23 June 2022
Declarations
:
: RS has received research support in the last 3 years from Janssen, GSK and Takeda.
: Ethical clearances have been obtained for this study (King’s College London: HR/DP-20/21-21567). Access to deidentified records from CRIS have been approved by an independent Research Ethics Committee (‘Oxfordshire C’; 18/SC/0372), and additional approvals to analyse data for this project have been provided by the CRIS Oversight committee. The CPRD has broad National Research Ethics Service Committee ethics approval for observational research studies and the protocol for this study received scientific and ethical approval from the Independent Scientific Advisory Committee for CPRD studies (ISAC Protocol 20_069).